Astex Pharmaceuticals is a pharmaceutical company focused on the discovery and development of novel small molecule therapeutics, with a focus on oncology. The company is currently engaged in developing a proprietary pipeline of novel therapies and is creating de-risked products … Continue reading →

Citigold Corporation is a gold mining company in Australia, with operations based at Charters Towers in northeastern Australia. Citigold is a growth company focused on growing its cash flow through expanding gold mining operations. The Charters Towers gold and silver … Continue reading →

Magic Software Enterprises is a worldwide provider of smarter technology that provides customers with a multi-channel user experience of enterprise logic and data. The company’s future-proof platforms offer a productive environment for streamlined development and deployment and effective integration of … Continue reading →

BioSpecifics Technologies, a biopharmaceutical company, has developed injectable collagenase (XIAFLEX) for 12 clinical indications. XIAFLEX is currently being marketed for the treatment of Dupuytren’s contracture and Peyronie’s disease by various companies in the U.S. and internationally. XIAFLEX is also in … Continue reading →

Titan Pharmaceuticals is a biopharmaceutical company engaged in developing products to treat central nervous system (CNS) diseases. Fanapt (iloperidone), the company’s first out-licensed product, is an atypical antipsychotic that was approved in the United States in 2009 for treating schizophrenia … Continue reading →

International Stem Cell Corporation is a biotechnology company focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. Parthenogenesis, the company’s core technology, creates pluripotent human stem cells … Continue reading →

Spectrum Pharmaceuticals, Inc. (NASDAQ-GS: SPPI) is a biotechnology company engaged in acquiring, developing and commercializing drug products, with its chief focus on oncology and hematology. The company currently markets two oncology drugs: FUSILEV for Injection in the United States, and … Continue reading →

DUSA Pharmaceuticals is an integrated dermatology pharmaceutical company chiefly engaged in the development and marketing of its Levulan PDT technology platform. The company’s Levulan Kerastick (aminolevulinic acid HCI) for Topical Solution, 20% plus blue light illumination using DUSA’s BLU-U Blue … Continue reading →

Idera Pharmaceuticals is focused on applying its proprietary Toll-like receptor (TLR) drug discovery platform to create immunomodulatory drug candidates. The company has clinical development programs in autoimmune diseases and cancer and also has a collaboration with Merck & Co. for … Continue reading →

Orexigen Therapeutics, a biopharmaceutical company, is focused on the treatment of obesity. Contrave, Orexigen’s lead product candidate, has completed Phase III clinical trials, and a New Drug Application has been submitted and reviewed by the U.S. Food and Drug Administration. … Continue reading →